Skip to main content

Table 2 Stone composition

From: The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients

Main constituent of stone(s)

Patients

Calcium oxalate monohydrate

21

Calcium phosphate stones

7

Cystine stones

3

Calcium hydroxyl phosphate

3

Calcium-oxalate dihydrate stones

3